Literature DB >> 24852092

Transdermal drug delivery: 30+ years of war and still fighting!

Sandra Wiedersberg1, Richard H Guy2.   

Abstract

By any measure, transdermal drug delivery (TDD) is a successful controlled release technology. Over the last 30+ years, a steady flux of transdermal products have received regulatory approval and reached the market. For the right compounds, TDD is an effective and preferred route of administration; for others, delivery across the skin makes no sense at all. Currently, the "rules" that govern (passive) TDD feasibility are clearly understood, and research activity is focused on novel approaches that strive to subvert skin's excellent barrier function, and broaden the range of active species amenable to percutaneous administration.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Controlled release; Skin barrier function; Transdermal drug delivery

Mesh：

Substances：

Year:  2014        PMID： 24852092     DOI： 10.1016/j.jconrel.2014.05.022

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


  33 in total

Review 1.  In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?

Authors:  Jie Shen; Diane J Burgess
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 2.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

3.  Physical immobilization of particles inspired by pollination.

Authors:  Lúcia F Santos; A Sofia Silva; Clara R Correia; João F Mano
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-04       Impact factor: 11.205

4.  Individually coated microneedles for co-delivery of multiple compounds with different properties.

Authors:  Song Li; Wei Li; Mark Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Enhanced skin permeation of glabridin using eutectic mixture-based nanoemulsion.

Authors:  Chen Liu; Jin Hu; Hong Sui; Qipeng Zhao; Xia Zhang; Wenping Wang
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 6.  Transdermal Delivery of Antipsychotics: Rationale and Current Status.

Authors:  Angela Abruzzo; Teresa Cerchiara; Barbara Luppi; Federica Bigucci
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

7.  A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.

Authors:  André Dallmann; Ibrahim Ince; Katrin Coboeken; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

8.  Modular Fabrication of Intelligent Material-Tissue Interfaces for Bioinspired and Biomimetic Devices.

Authors:  John R Clegg; Angela M Wagner; Su Ryon Shin; Shabir Hassan; Ali Khademhosseini; Nicholas A Peppas
Journal:  Prog Mater Sci       Date:  2019-07-17

Review 9.  An update on the use of transdermal oxybutynin in the management of overactive bladder disorder.

Authors:  Joshua A Cohn; Elizabeth T Brown; W Stuart Reynolds; Melissa R Kaufman; Douglas F Milam; Roger R Dmochowski
Journal:  Ther Adv Urol       Date:  2016-01-19

10.  Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.

Authors:  Cornel Burger; Marique Aucamp; Jan du Preez; Richard K Haynes; Andile Ngwane; Jeanetta du Plessis; Minja Gerber
Journal:  Pharm Res       Date:  2018-08-07       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.